- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2019-005017-39.
Displaying page 1 of 1.
EudraCT Number: 2019-005017-39 | Sponsor Protocol Number: SGNTUC-016 | Start Date*: 2021-01-08 | ||||||||||||||||
Sponsor Name:Seagen Inc. | ||||||||||||||||||
Full Title: Randomized, double-blind, phase 3 study of tucatinib or placebo in combination with ado-trastuzumab emtansine (T-DM1) for subjects with unresectable locally-advanced or metastatic HER2+ breast canc... | ||||||||||||||||||
Medical condition: Unresectable locally-advanced or metastatic HER2+ breast cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Ongoing) DK (Ongoing) FR (Ongoing) AT (Completed) BE (Ongoing) GB (GB - no longer in EU/EEA) NL (Ongoing) SE (Ongoing) IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
